Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5281886
Max Phase: Preclinical
Molecular Formula: C18H21N7O
Molecular Weight: 351.41
Associated Items:
ID: ALA5281886
Max Phase: Preclinical
Molecular Formula: C18H21N7O
Molecular Weight: 351.41
Associated Items:
Canonical SMILES: Nc1cnc(-c2cc(N3C[C@@H]4C[C@H]3CO4)nc(N3CC4CC3C4)n2)cn1
Standard InChI: InChI=1S/C18H21N7O/c19-16-6-20-15(5-21-16)14-4-17(24-8-13-3-12(24)9-26-13)23-18(22-14)25-7-10-1-11(25)2-10/h4-6,10-13H,1-3,7-9H2,(H2,19,21)/t10?,11?,12-,13-/m0/s1
Standard InChI Key: XGFVOKJJQCQLJX-TYUFSLCMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 351.41 | Molecular Weight (Monoisotopic): 351.1808 | AlogP: 1.09 | #Rotatable Bonds: 3 |
Polar Surface Area: 93.29 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 4.90 | CX LogP: 1.43 | CX LogD: 1.43 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.88 | Np Likeness Score: -0.23 |
1. Craig RA, Fox BM, Hu C, Lexa KW, Osipov M, Thottumkara AP, Larhammar M, Miyamoto T, Rana A, Kane LA, Yulyaningsih E, Solanoy H, Nguyen H, Chau R, Earr T, Kajiwara Y, Fleck D, Lucas A, Haddick PCG, Takahashi RH, Tong V, Wang J, Canet MJ, Poda SB, Scearce-Levie K, Srivastava A, Sweeney ZK, Xu M, Zhang R, He J, Lei Y, Zhuo Z, de Vicente J.. (2022) Discovery of Potent and Selective Dual Leucine Zipper Kinase/Leucine Zipper-Bearing Kinase Inhibitors with Neuroprotective Properties in In Vitro and In Vivo Models of Amyotrophic Lateral Sclerosis., 65 (24.0): [PMID:36469401] [10.1021/acs.jmedchem.2c01056] |
Source(1):